nointervention
OtherNointervention
NCT Number: NCT04943393
PKU is a rare autosomal recessive condition associated with disruption in dopamine synthesis. Although early diagnosis and treatment prevent the severe impairments associated with untreated PKU, individuals with early-treated PKU (ETPKU) nonetheless experience significant sequelae, including impaired working memory and increased risk for anxiety problems. Past research with other clinical populations (e.g., generalized anxiety disorder) suggests that the two phenomena may be linked, with increased anxiety contributing to poorer WM performance. Currently we propose to initiate an exciting new line of research examining the potential relationship between anxiety and WM in ETPKU. The proposed study will also apply remote neuropsychological performance-based assessment to the study of ETPKU and thus overcoming the geographical limitations/challenges associated with recruitment of participants with this rare disease.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Observational
Emory University, Atlanta, Georgia, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Nointervention
Time frame: 2.5-3 hrs total over approx 1-3 weeks
Composite score based on multiple working memory-related CANTAB tests
University of Missouri-Columbia
Other
Remote Assessment of Working Memory and Anxiety in Individuals With Early-Treated Phenylketonuria (PKU)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03856203
Amino Acid Metabolism, Inborn Errors, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT05051657
Amino Acid Metabolism, Inborn Errors, Brain Diseases
Belfast, United Kingdom
View Trial DetailsNCT04679467
Amino Acid Metabolism, Inborn Errors, Brain Diseases
Bologna, Italy
View Trial DetailsNCT05487378
Amino Acid Metabolism, Inborn Errors, Brain Diseases
Birmingham, United Kingdom
View Trial Details